General Information of Drug (ID: DMY6QOR)

Drug Name
KC-12291 Drug Info
Synonyms KC-12291; CHEMBL452043; SCHEMBL6577701; kc12291; ZINC1545352; NCGC00370808-01
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
10364418
TTD Drug ID
DMY6QOR

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Mephenytoin DM5UGDK Epilepsy 8A60-8A68 Approved [2]
Mexiletine DMCTE9R Ventricular tachycardia BC71 Approved [3]
Fosphenytoin DMOX3LB Epilepsy 8A60-8A68 Approved [2]
Disopyramide DM5SYZP Long QT syndrome BC65.0 Approved [3]
LOMERIZINE DME0TC8 Migraine 8A80 Approved [4]
Tetrodotoxin DMWMPRG Bacterial infection 1A00-1C4Z Approved [5]
Dyclonine DMU6OFP Pain MG30-MG3Z Approved [6]
Moricizine DMOMBJW Arrhythmia BC9Z Approved [7]
Ethotoin DMXWOCP Complex partial seizure 8A68.0 Approved [8]
Prilocaine DMI7DZ2 Pain MG30-MG3Z Approved [6]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Voltage-gated sodium channel alpha Nav1.5 (SCN5A) TTZOVE0 SCN5A_HUMAN Inhibitor [1]

References

1 Sodium late current blockers in ischemia reperfusion: is the bullet magic J Med Chem. 2008 Jul 10;51(13):3856-66.
2 Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders. CNS Drugs. 2009;23(7):555-68.
3 Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol. 2000 Dec;11(12):1320-9.
4 Medicinal chemistry of neuronal voltage-gated sodium channel blockers. J Med Chem. 2001 Jan 18;44(2):115-37.
5 Halothane attenuates the cerebroprotective action of several Na+ and Ca2+ channel blockers via reversal of their ion channel blockade. Eur J Pharmacol. 2002 Oct 4;452(2):175-81.
6 Monoamine transporter and sodium channel mechanisms in the rapid pressor response to cocaine. Pharmacol Biochem Behav. 1998 Feb;59(2):305-12.
7 From first class to third class: recent upheaval in antiarrhythmic therapy--lessons from clinical trials. Am J Cardiol. 1996 Aug 29;78(4A):28-33.
8 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.